<DOC>
	<DOCNO>NCT00008372</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness chloroquinoxaline sulfonamide treat patient small cell lung cancer respond platinum-based chemotherapy .</brief_summary>
	<brief_title>Chloroquinoxaline Sulfonamide Treating Patients With Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy chloroquinoxaline sulfonamide patient platinum-refractory small cell lung cancer . II . Determine toxic effect drug patient . OUTLINE : Patients receive chloroquinoxaline sulfonamide IV 1 hour week 4 week . Treatment repeat every 6 week absence disease progression unacceptable toxicity . Patients follow death . PROJECTED ACCRUAL : A total 12-38 patient accrue study within 12-18 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Sulfanilamides</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm platinumrefractory small cell lung cancer No response progression within 6 month complete platinum base therapy Measurable disease No symptomatic brain leptomeningeal metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : SWOG 02 Life expectancy : At least 12 week Hematopoietic : Granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 No hemolytic anemia Hepatic : Bilirubin normal AST great 2.5 time upper limit normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular : No history cardiac arrhythmia Other : No active malignancy require concurrent treatment No allergy sulfonamides Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No 2 prior chemotherapy regimen At least 3 week since prior chemotherapy recover Endocrine therapy : No concurrent corticosteroid control symptoms brain and/or leptomeningeal metastasis Radiotherapy : At least 4 week since prior radiotherapy No concurrent radiotherapy measurable lesion Surgery : Not specify Other : No concurrent hypoglycemic agent ( include insulin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
</DOC>